Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.

ABSTRACT:

SUBMITTER: Lamb CA 

PROVIDER: S-EPMC8207069 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature